The dawn of a new era in the treatment of HCV infection: A view from the USA.
作者信息
Pockros Paul J
机构信息
Liver Disease Center Scripps Clinic, and the Scripps Translational Science Institute La Jolla CA.
出版信息
Clin Liver Dis (Hoboken). 2014 Dec 9;4(5):107-108. doi: 10.1002/cld.419. eCollection 2014 Nov.
Abstract
摘要
相似文献
1
The dawn of a new era in the treatment of HCV infection: A view from the USA.丙型肝炎病毒感染治疗新时代的曙光：来自美国的视角
Clin Liver Dis (Hoboken). 2014 Dec 9;4(5):107-108. doi: 10.1002/cld.419. eCollection 2014 Nov.
2
Epidemiological trends among the population with chronic HCV infection in the Netherlands.荷兰慢性丙型肝炎病毒感染人群的流行病学趋势。
Antivir Ther. 2016;21(3):207-15. doi: 10.3851/IMP2996. Epub 2015 Oct 5.
3
Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era.索磷布韦治疗慢性丙型肝炎的疗效与安全性：新时代的曙光
Rev Recent Clin Trials. 2014;9(1):1-7. doi: 10.2174/1574887108666131213120354.
4
Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.接受高效抗逆转录病毒治疗（HAART）前后，HIV感染退伍军人患糖尿病的风险以及丙型肝炎病毒（HCV）合并感染的作用。
Hepatology. 2004 Jul;40(1):115-9. doi: 10.1002/hep.20289.
5
Cutaneous manifestations of hepatitis C in the era of new antiviral agents.新型抗病毒药物时代丙型肝炎的皮肤表现
World J Hepatol. 2015 Nov 28;7(27):2740-8. doi: 10.4254/wjh.v7.i27.2740.
6
Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.直接作用抗病毒治疗时代 HCV 抗体阳性的已故供肾的使用和废弃的变化。
Transplantation. 2018 Dec;102(12):2088-2095. doi: 10.1097/TP.0000000000002323.
7
Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.直接作用抗病毒药物时代肝移植治疗丙型肝炎病毒感染者的移植物存活率提高。
Liver Transpl. 2019 Apr;25(4):598-609. doi: 10.1002/lt.25424.
8
Decreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort study.直接作用抗病毒药物时代丙型肝炎相关肝移植的频率降低和结局改善：一项回顾性队列研究。
Transpl Int. 2019 Aug;32(8):854-864. doi: 10.1111/tri.13424. Epub 2019 Mar 26.
9
Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.丙型肝炎病毒感染的免疫遗传学研究在泛基因型抗病毒治疗时代-有效治疗即将到来。
Infect Genet Evol. 2018 Dec;66:376-391. doi: 10.1016/j.meegid.2017.08.011. Epub 2017 Aug 12.
10
[FIRST GENERATION PROTEASE INHIBITOR BASED TRIPLE THERAPY FOR HCV GENOTYPE 1--LOOKING BACK WHILE PROCEEDING TO A PROMISING ERA].[基于第一代蛋白酶抑制剂的丙型肝炎病毒1型三联疗法——迈向充满希望的时代之际的回顾]
Harefuah. 2016 May;155(5):272-5, 324, 323.
本文引用的文献
1
Sofosbuvir and ribavirin in HCV genotypes 2 and 3.索磷布韦和利巴韦林治疗 2 型和 3 型丙型肝炎病毒。
N Engl J Med. 2014 May 22;370(21):1993-2001. doi: 10.1056/NEJMoa1316145. Epub 2014 May 4.
2
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.ABT-450/r-ombitasvir 和 dasabuvir 联合或不联合利巴韦林治疗 HCV。
N Engl J Med. 2014 May 22;370(21):1983-92. doi: 10.1056/NEJMoa1402338. Epub 2014 May 4.
3
Therapy of hepatitis C--back to the future.丙型肝炎的治疗——回归未来。
N Engl J Med. 2014 May 22;370(21):2043-7. doi: 10.1056/NEJMe1403619. Epub 2014 May 4.
4
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.来迪派韦索磷布韦片与索磷布韦联用治疗初治的 HCV 基因 1 型感染。
N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.
5
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.来迪派韦索磷布韦片治疗既往治疗的 HCV 基因 1 型感染。
N Engl J Med. 2014 Apr 17;370(16):1483-93. doi: 10.1056/NEJMoa1316366. Epub 2014 Apr 11.
6
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.ABT-450/r-ombitasvir 和 dasabuvir 联合利巴韦林治疗肝硬化合并丙型肝炎。
N Engl J Med. 2014 May 22;370(21):1973-82. doi: 10.1056/NEJMoa1402869. Epub 2014 Apr 11.
7
Therapy for hepatitis C--the costs of success.丙型肝炎治疗——成功的代价。
N Engl J Med. 2014 Apr 17;370(16):1552-3. doi: 10.1056/NEJMe1401508. Epub 2014 Apr 11.
8
Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.ABT-450/r-ombitasvir 和利巴韦林联合治疗 HCV。
N Engl J Med. 2014 Apr 24;370(17):1594-603. doi: 10.1056/NEJMoa1315722. Epub 2014 Apr 10.
9
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.聚乙二醇干扰素α-2a 联合利巴韦林治疗慢性丙型肝炎
N Engl J Med. 2014 May 15;370(20):1879-88. doi: 10.1056/NEJMoa1402355. Epub 2014 Apr 10.
10
Treating hepatitis C in lower-income countries.在低收入国家治疗丙型肝炎。
N Engl J Med. 2014 May 15;370(20):1869-71. doi: 10.1056/NEJMp1400160. Epub 2014 Apr 10.
Zotero 插件